Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 Jan-Feb;14(1):29-35.

Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin

Affiliations
  • PMID: 8169675
Clinical Trial

Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin

A Simko et al. J Perinatol. 1994 Jan-Feb.

Abstract

In a randomized study, indomethacin was administered either by an intravenous rapid infusion or by a 30-minute intravenous infusion to preterm infants. Ten infants were randomly assigned to the rapid infusion group and nine to the other group. Time-averaged mean systolic, mean flow velocity, and mean diastolic blood flow velocities were measured in the internal carotid artery with a pulsed Doppler. Blood flow velocities, arterial blood gases, intraarterial blood pressures, and transcutaneous PO2 and PCO2 were measured at 5 and 1 minutes before indomethacin and then at 5, 10, 20, 30, 35, 40, 50, 60, and 90 minutes after indomethacin administration. Intravenous indomethacin either by rapid or slow infusion caused a significant decrease in the blood flow velocities. The blood flow velocities were significantly lower 5 minutes after rapid infusion and by 30 minutes in the slow-infusion group. In both groups, the blood flow velocities remained depressed up to 90 minutes. The blood pressures increased concomitantly to the blood flow velocities in the rapid-administration group only. Because indomethacin given for 30 minutes does not avoid the decrease in the blood flow velocities, further studies are necessary to ascertain the safest method of administration.

PubMed Disclaimer

MeSH terms